Public Release: 

Best way to prepare fat cells for grafting? The jury's still out...

Wolters Kluwer Health

September 28, 2015 - Fat grafting--taking fat from one area of the body and transferring it elsewhere--has become a widely used plastic surgery technique. But what's the best method of processing cells for fat grafting procedures? Available research data still can't settle that long-running debate, according to a review in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

The updated review finds no "compelling evidence" to recommend any single technique as the best method for processing harvested fat cells for fat grafting, write ASPS Member Surgeon Alexes Hazen, MD, and colleagues of New York University Institute of Reconstructive Plastic Surgery. While studies show several viable methods of fat processing, more research is needed to compare the outcomes of current methods and evaluate some promising new techniques.

Latest Studies Show No Single Best Cell-Processing Technique

The researchers reviewed the scientific literature to analyze the most recent studies of methods to process harvested fat cells, or "lipoaspirate." In fat grafting, the patient's own (autologous) fat cells are obtained by liposuction from one part of the body, such as the abdomen, then transferred to another part of the body.

While the idea of fat grafting isn't new, in recent years it has become widely used for a wide range of plastic surgery procedures. One common use is to aid in reconstructive or cosmetic breast surgery, such as breast augmentation. Other purposes include facelifting--in one recent survey, 85 percent of plastic surgeons said they use fat grafting during facelift procedures.

The new analysis built on a previous review of 37 studies published through 2011. That report, also published in Plastic and Reconstructive Surgery, "revealed a lack of high-quality data despite the increase in fat grafting over the past 20 years."

Dr. Hazen and colleagues identified nine additional articles published through 2014. Five studies evaluated established techniques for processing the lipoaspirate: "decanting, cotton gauze rolling, centrifugation, and washing." While none of these techniques is clearly superior to the others, the studies do identify "several viable methods" of processing samples for fat grafting.

Each technique has its strengths and limitations. For example, cotton-gauze rolling removes contaminants, but is labor-intensive. Centrifugation is probably the most common technique, but there is no evidence that it's superior to other methods.

Four studies evaluated new, proprietary techniques for cell processing, such as cell washing or filtration techniques. Some methods are designed to isolate the "stromal vascular fraction" of the harvested fat tissue--with the goal of preserving stem cells and other specialized fat cells.

Several techniques have been shown to successfully isolate the stromal vascular fraction. However, Dr. Hazen and coauthors write, "A great deal of further research is required in order to determine whether this additional cost and effort is justified by superior clinical outcomes."

Thus while the use of fat grafting for cosmetic and reconstructive plastic surgery continues to expand, the updated review shows a continued lack of evidence on the best fat processing techniques to provide the best clinical outcomes for patients. Dr. Hazen and colleagues conclude, "Despite continued exploration in this field, further research...[is] required to identify the optimal methods for processing harvested adipose tissue into the ideal autologous graft."


Click here to read "Roll, Spin, Wash, or Filter? Processing of Lipoaspirate for Autologous Fat Grafting: An Updated, Evidence-Based Review of the Literature."

Article: "Roll, Spin, Wash, or Filter? Processing of Lipoaspirate for Autologous Fat Grafting: An Updated, Evidence-Based Review of the Literature" (doi: 10.1097/PRS.0000000000001581)

Plastic and Reconstructive Surgery® is published by Wolters Kluwer.

About Plastic and Reconstructive Surgery

For more than 60 years, Plastic and Reconstructive Surgery® ( has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. You can learn more and visit the American Society of Plastic Surgeons at or and

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.